Clinical trial
Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in…
NCT00033475 · University of Edinburgh, Other · Completed
Key facts
| NCT number | NCT00033475 |
|---|---|
| Title | Reduced Immunosuppressive Therapy With or Without Donor White Blood Cells in Treating Patients With Lymphoproliferative Disease After Organ Transplantation |
| Official title | Cytotoxic T Cell Therapy for Post Transplant Lymphoproliferative Disease: Randomized Controlled Trial in Transplant Recipients |
| Lead sponsor | University of Edinburgh, Other |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Lymphoproliferative Disorder |
| Intervention type | Biological |
| Interventions | therapeutic allogeneic lymphocytes |
| Enrollment | 50 |
| Start date | Mar 1, 2001 |
| First posted | Jan 27, 2003 |
| Last update posted | Jan 15, 2026 |
| Countries | United Kingdom |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: